UPMC Hillman Cancer Center immunologist, Greg Delgoffe is the first recipient of the newly established Sy Holzer Endowed Immunotherapy Research Fund to advance innovative research in cancer immunotherapy.
With major leadership changes, grant disruptions and terminations, and a stoked distrust in science, Steven Artandi, the director of Stanford Cancer Center, worries that young investigators will feel disenchanted by the U.S. research atmosphere and take their work and study elsewhere.
